Trileptal
Quick Facts
Oxcarbazepine
Date Approved
January 14 2000
Manufacturer
Novartis
Status
On the market
Approved Uses
Epileptic Seizures
Off Label Uses
Bipolar Disorder
Schizoaffective Disorder
Neuropathic pain
OCD
Serious Side Effects
Stevens Johnson Syndrome
Toxic Epidermal Necrolysis
Organ hypersensitivity
Related Topics
Protopic
Stevens Johnson Syndrome
Toxic Epidermal Necrolysis
Defective Drugs
Diseases
CLICK HERE TO DOWNLOAD OUR TRILEPTAL INFORMATION PACKAGE
Trileptal Side Effects May Result In Stevens-Johnson Syndrome Lawsuits
Trileptal | Lawsuits, Lawyers | Side Effects: Dermatological Reactions, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN)
Trileptal (Generic: Oxcarbazepine) is an antiepileptic drug that has been approved by the U.S. Food and Drug Administration and is indicated for use as monotherapy (by itself) or adjunctive therapy (taken with other medications) in the treatment of partial seizures in adults and children 4 years of age and older with epilepsy.
Novartis Pharmaceuticals and the FDA notified healthcare professionals about revisions to the warnings and precautions sections of the prescribing information for Trileptal tablets and oral suspension. The updated warnings section describes serious dermatological reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), that have been reported in both children and adults in association with Trileptal use. The PRECAUTIONS section has been updated to include language regarding multi-organ hypersensitivity reactions that have been reported in association with Trileptal use. Trileptal has been available in the United States since February 2000, and has been prescribed for over 250,000 patients. In 2004, sales of Trileptal totaled $391 million.
Legal Help For Victims Affected By Trileptal
If you or a loved one took Trileptal and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us anytime at 1-800-LAW-INFO (1-800-529-4636).










